JNJ

Big Pharma Stocks: Year in Review
Yahoo/TheStreet.com
Tue, 12/24/13 - 09:50 am
Big Pharma
drug stocks
Merck
JNJ
GSK
Eli Lilly
Pfizer
Sanofi
Bristol-Myers Squibb
Biogen's Biosimilars Vs. Amgen, Johnson & Johnson
Seeking Alpha
Mon, 12/23/13 - 10:01 am
Amgen
Biogen Idec
biosimilars
JNJ
Samsung Bioepis
Celltrion
Hospira
Remsima
Inflectra
Biotech Stocks: A Year in Review
Yahoo/TheStreet.com
Fri, 12/20/13 - 08:34 am
Amgen
Teva
Forest Labs
AstraZeneca
Medivation
JNJ
FDA Puts Out Warning on J&J, Novartis ADHD Drugs
Wall St Cheat Sheet
Tue, 12/17/13 - 03:01 pm
JNJ
FDA
ADHD
Novartis
methylphenidate
Ritalin
Concerta
Keep an Eye on Biogen, Johnson & Johnson, and Merck Today
Motley Fool
Tue, 12/17/13 - 10:42 am
Biogen Idec
JNJ
Merck
Bravecto
animal health
Samsung
Hospira
Amgen
AbbVie
anti-TNF
Decision Diagnostics Receives Mandate From U.S. Court of Appeals for the Federal Circuit in the Long Running Dispute With J&J Division
Yahoo
Tue, 12/17/13 - 10:34 am
Decision Diagnostics
JNJ
patents
diagnostics
Shasta GenStrip
Lifescan Ultra
Possible New Lease On Life For Two Cardiology Drugs From Merck And J&J
Forbes
Mon, 12/16/13 - 02:16 pm
Merck
JNJ
Zontivity
Vorapaxar
Xarelto
J&J's combo diabetes drug held up by FDA
PM Live
Mon, 12/16/13 - 08:29 am
canagliflozin
diabetes
JNJ
metformin
FDA
Invokana
Ziopharm: Finally A Winner In The War On Cancer?
Seeking Alpha
Mon, 12/16/13 - 08:06 am
Ziopharm
cancer
AbbVie
Amgen
Celgene
Celldex Therapeutics
Gilead Sciences
Immunogen
JNJ
ImmunoCellular Therapeutics
Pharmacyclics
Intrexon
Seattle Genetics
Report: Johnson & Johnson Has $4B Bids for Ortho Clinical
Wall St Cheat Sheet
Sun, 12/15/13 - 12:48 pm
JNJ
Ortho Clinical Diagnostics
M&A
Celgene and Pharmacyclics Bring Big Change to Mantle Cell Lymphoma in 2013
Motley Fool
Sat, 12/14/13 - 12:03 pm
Celgene Corporation
Pharmacyclics
mantle cell lymphoma
JNJ
Imbruvica
Revlimid
Novartis: 2 Novel Cancer Therapies Show Promising Results
Seeking Alpha
Wed, 12/11/13 - 02:42 pm
Novartis
Celgene
JNJ
Merck
panobinostat
Multiple Myeloma
acute lymphocytic leukemia
What Is Johnson & Johnson's Opportunity In Hepatitis C Market?
Forbes
Wed, 12/11/13 - 09:01 am
JNJ
hepatitis C
Olysio
J&J taps UK research hubs
The Telegraph, UK
Tue, 12/10/13 - 09:44 am
JNJ
R&D
UK
EU regulators fine J&J, Novartis 16 mln euros for generic drug deal
Yahoo/Reuters
Tue, 12/10/13 - 09:25 am
Europe
Novartis
generics
JNJ
Fentanyl
J&J, Roche, Novartis tout key cancer-drug data at ASH
Fierce Pharma
Mon, 12/9/13 - 10:12 am
JNJ
Roche
Novartis
Imbruvica
Tasigna
CLL
Gazyva
How Risperdal Whistle-Blowers Made Millions From J&J
Bloomberg
Mon, 12/9/13 - 08:40 am
Risperdal
JNJ
whistleblower lawsuits
whistleblowers
J&J’s Drug Shows Promise for Rare Castleman Disease
Bloomberg
Sun, 12/8/13 - 12:20 pm
JNJ
siltuximab
multicentric Castleman disease
Johnson & Johnson Battles St. Jude for Cardiac Mapping Leadership
Motley Fool
Sat, 12/7/13 - 12:56 pm
JNJ
St. Jude Medical
cardiac mapping
What Everybody Ought to Know About Gilead and Johnson & Johnson's New Hepatitis C Drugs
Seeking Alpha
Fri, 12/6/13 - 10:30 am
JNJ
Gilead Sciences
hepatitis C
sofosbuvir
Olysio
AbbVie
Bristol-Myers Squibb
Merck

Pages